Track topics on Twitter Track topics that are important to you
Viral exanthema refers to widespread skin rash followed by high fever, observed in infants and caused due to viral infection. Rashes are usually occurring on arms, legs and trunk in the form of pink to red spots. These rashes may or may not be itchy in nature and sometimes the patient may suffer from fever, fatigue, loss of appetite, pains, headache and irritability. Treatment is required in cases of severe symptoms such as diarrhea, vomiting, severe abdominal pain, seizures, stiff neck, red eyes and sputum with pus or blood. However, certain medications can be taken for low fever, headaches and pains and others. Globally, increasing research activities for development of novel therapeutics against viral exanthema symptoms, rise in susceptibility of infants towards these infections due to weak immune system, and increasing government support are the prime growth drivers of global exanthema market. In addition, increase in cases of exanthema in emerging economies such as China, India, Brazil and others, will create new opportunities for global exanthema market. However, higher cost of the research, negligence towards diagnosing the symptoms, and lack of standardization are the key restraints for global exanthema market.
This report identifies the global exanthema market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global exanthema market.
Geographically North America dominated global exanthema market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness levels, modernizing healthcare infrastructure, and favourable government support in this region. Chloroamphenicol sodium succinate, tazarotene and threolone are some of the drugs in the investigational phases for treatment of exanthema.
This report segments global exanthema market on the basis of type, and regional market as follows:
Exanthema Market, By Product: Rubeola, Rubella, Erythema Infectiosum, and Roseola Infantum
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region
This report identifies all the major companies operating in the exanthema market. Some of the major companies' profiles in detail are as follows:
Manus Aktteva Biopharma LLP
Teva Pharmaceutical Industries Ltd.
CIRON Drugs Pharmaceuticals Pvt. Ltd.
Iol Chemicals And Pharmaceuticals Limited
Reckitt Benckiser Group plc
Original Article: Exanthema Market: By Type Rubeola, Rubella, Erythema Infectiosum, and Roseola Infantum, By Geography Europe, Asia Pacific, North America, Rest of the World Forecast 20162021 [Updated: 24022016] Prices from USD $5250NEXT ARTICLE
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...